Compare ARK Genomic Revolution ETF (ARKG) vs Global X SuperDividend ETF (SDIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Global X SuperDividend ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.2, while Global X SuperDividend ETF trades at $24.54. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Global X SuperDividend ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | SDIV | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $26.34 |
52-Week Low | $23.09 | $22.90 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
SDIV trades at $24.60, up 0.94% in the past 24 hours, with a bearish technical signal driven by moving averages. The ETF offers a high dividend yield, recently paying $0.18 per share quarterly, attracting income-focused investors. Recent news highlights its appeal for diversification away from tech and its 9.29% yield, though valuation ratios like P/E and P/B are unavailable. Support and resistance cluster around $24-$25, indicating tight price consolidation.
Outlook remains mixed; the high yield and non-tech exposure provide income opportunities, but bearish technicals and reliance on global small-cap value stocks pose risks. Investors should weigh the attractive dividends against potential volatility from economic shifts and sector concentration in Financials and Energy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Global X SuperDividend ETF
SDIV is an ETF that invests in 100 of the highest dividend-yielding equity securities in the world. The fund seeks to provide a high level of income to investors by selecting companies from both developed and emerging markets that have historically provided high dividend yields. By diversifying globally, SDIV aims to mitigate risks associated with focusing on a single country, while offering monthly distributions to its shareholders.
Read more on SDIV →
